Oncology-banner-top1

Oncology

Our mission is to deliver innovations that extend and improve the lives of people with cancer.

Keytruda Logo
Prescribing information
  1. Garassino MC, Gadgeel S, Speranza G, et al. KEYNOTE-189 5-year update: First-line pembrolizumab + pemetrexed and platinum vs placebo + pemetrexed and platinum for metastatic no squamous NSCLC. Slide deck presented at: European Society for Medical Oncology (ESMO) European Lung Cancer Virtual Congress (ELCC); 9–13 September 2022; Paris, France.
  2. Novello S, Kowalski DM, Lu􀃻 A, et al. 5-year update from KEYNOTE-407: pembrolizumab plus chemotherapy in squamous non‒small-cell lung cancer. Slide deck presented at: European Society for Medical Oncology (ESMO) European Lung Cancer Virtual Congress (ELCC); 9–13 September 2022; Paris, France.